OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Drug safety in hospitalized patients with tuberculosis: Drug interactions and adverse drug effects
Sidra Noor, Mohammad Ismail, Fahadullah Khan
The Clinical Respiratory Journal (2020) Vol. 15, Iss. 1, pp. 97-108
Closed Access | Times Cited: 10
Sidra Noor, Mohammad Ismail, Fahadullah Khan
The Clinical Respiratory Journal (2020) Vol. 15, Iss. 1, pp. 97-108
Closed Access | Times Cited: 10
Showing 10 citing articles:
Enhancing Tuberculosis Patient Safety: The Impact of Interprofessional Collaboration based Telecare on Drug-Related Problems in a Randomized Control Trial
Devi Ristian Octavia, Andi Hermansyah, Yunita Nita, et al.
Indian Journal of Tuberculosis (2025)
Closed Access
Devi Ristian Octavia, Andi Hermansyah, Yunita Nita, et al.
Indian Journal of Tuberculosis (2025)
Closed Access
Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models
Levin Thomas, Arun Prasath Raju, S. Chaithra, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 10, pp. 1535-1553
Open Access | Times Cited: 18
Levin Thomas, Arun Prasath Raju, S. Chaithra, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 10, pp. 1535-1553
Open Access | Times Cited: 18
Diagnostic value of microRNAs in active tuberculosis based on quantitative and enrichment analyses
Shuoyi Yao, Bin Liu, Xinyue Hu, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 108, Iss. 4, pp. 116172-116172
Closed Access | Times Cited: 3
Shuoyi Yao, Bin Liu, Xinyue Hu, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 108, Iss. 4, pp. 116172-116172
Closed Access | Times Cited: 3
A narrative review of tuberculosis in the United States among persons aged 65 years and older
Iris L Wu, Amit S. Chitnis, Devan Jaganath
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (2022) Vol. 28, pp. 100321-100321
Open Access | Times Cited: 14
Iris L Wu, Amit S. Chitnis, Devan Jaganath
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (2022) Vol. 28, pp. 100321-100321
Open Access | Times Cited: 14
Structure-Based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment
Wei Zhang, Shichun Lun, Shuangshuang Wang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13240-13252
Closed Access | Times Cited: 13
Wei Zhang, Shichun Lun, Shuangshuang Wang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13240-13252
Closed Access | Times Cited: 13
The identification of key metabolites and mechanisms during isoniazid/rifampicin-induced neurotoxicity and hepatotoxicity in a mouse model by HPLC-TOF/MS-based untargeted urine metabolomics
Yanqing Song, Jie Ma, Huan Gao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 236, pp. 115709-115709
Closed Access | Times Cited: 5
Yanqing Song, Jie Ma, Huan Gao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 236, pp. 115709-115709
Closed Access | Times Cited: 5
Predictors for Pulmonary Tuberculosis Outcome and Adverse Events in an Italian Referral Hospital: A Nine-Year Retrospective Study (2013–2021)
Francesco Di Gennaro, Rossana Lattanzio, Giacomo Guido, et al.
Annals of Global Health (2022) Vol. 88, Iss. 1
Open Access | Times Cited: 8
Francesco Di Gennaro, Rossana Lattanzio, Giacomo Guido, et al.
Annals of Global Health (2022) Vol. 88, Iss. 1
Open Access | Times Cited: 8
The gut and lung microbiota in pulmonary tuberculosis: susceptibility, function, and new insights into treatment
Qiqi Zhuo, Xianyi Zhang, Kehong Zhang, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 12, pp. 1355-1364
Open Access | Times Cited: 3
Qiqi Zhuo, Xianyi Zhang, Kehong Zhang, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 12, pp. 1355-1364
Open Access | Times Cited: 3
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
Dario Cattaneo, Alessandro Torre, Marco Schiuma, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1171-1171
Open Access | Times Cited: 2
Dario Cattaneo, Alessandro Torre, Marco Schiuma, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1171-1171
Open Access | Times Cited: 2
Pharmacists’ Role in Global TB Elimination: Practices, Pitfalls, and Potential
Alina Cernasev, Jonathan Stillo, Jolie Black, et al.
Healthcare (2024) Vol. 12, Iss. 11, pp. 1137-1137
Open Access
Alina Cernasev, Jonathan Stillo, Jolie Black, et al.
Healthcare (2024) Vol. 12, Iss. 11, pp. 1137-1137
Open Access
Alcohol Consumption As A Risk Factor For Anti-tuberculosis Drug Induced Liver Injury: A Systematic Review And Meta-analysis
Fan Zhang, Fuzhen Zhang, Mingyang Qin, et al.
Microbial Pathogenesis (2024) Vol. 196, pp. 107003-107003
Closed Access
Fan Zhang, Fuzhen Zhang, Mingyang Qin, et al.
Microbial Pathogenesis (2024) Vol. 196, pp. 107003-107003
Closed Access
